Results 31 to 40 of about 2,577 (168)

Revisiting nocardiosis at a tertiary care institution: Any change in recent years?

open access: yesInternational Journal of Infectious Diseases, 2021
Objective: To analyse relevant changes in incidence, clinical and microbiological characteristics of nocardiosis over the last 24 years at the current institution.
Alicia Galar   +7 more
doaj   +1 more source

Clinical spectrum and outcome of pulmonary nocardiosis: 5-year experience

open access: yesLung India, 2016
Background: Pulmonary nocardiosis is a rare but a life-threatening infection caused by Nocardia spp. The diagnosis is often missed and delayed resulting in delay in appropriate treatment and thus higher mortality.
Akashdeep Singh   +4 more
doaj   +1 more source

Brain metastasis or nocardiosis? A case report of central nervous system Nocardiosis with a review of the literature

open access: yesJournal of Community Hospital Internal Medicine Perspectives, 2021
Nocardiosis is an infection caused by the gram-positive bacterium Nocardia, which typically manifests as an isolated pulmonary or systemic disease. Of note, Nocardia has a predilection for the central nervous system (CNS) involvement, which is more ...
Hojin Sun   +2 more
doaj   +1 more source

MRI findings in patient with primary cutaneous nocardiosis: A case report

open access: yesRadiology Case Reports, 2023
Nocardia is a genus of gram-positive, filamentous, aerobic bacteria that belongs to the Actinomycetales order. With over 50 species, it is ubiquitous in dust, soil, decaying organic matter, and stagnant water.
Alfonso Reginelli, PhD   +8 more
doaj   +1 more source

Pulmonary Nocardiosis with Aspergillosis in a patient with COPD: A rare co-infection

open access: yesIDCases, 2020
Pulmonary Nocardiosis and invasive Aspergillosis are well documented in immunocompromised patients. The coexistence of both infections is a diagnostic rarity, especially in patients with underlying structural lung diseases.
Durga Shankar Meena   +8 more
doaj   +1 more source

Case report: Nocardia gipuzkoensis infection in an immunocompetent patient diagnosed by metagenomic next-generation sequencing and whole genome sequencing

open access: yesFrontiers in Immunology, 2022
The infection of Nocardia gipuzkoensis is a relatively uncommon form of pulmonary nocardiosis seen in clinical patients. In general, nocardiosis tends to occur in patients with immune deficiency.
Chengxin Liu   +5 more
doaj   +1 more source

Nocardiosis in a tertiary care hospital in Saudi Arabia

open access: yesJournal of Global Infectious Diseases, 2011
Background: Nocardiosis is an uncommon bacterial infection that is caused by aerobic actinomycetes of the genus Nocardia. This pathogen has emerged as an important cause of mortality and morbidity among both immunocompetent and (more commonly ...
Hamdan Al-Jahdali   +4 more
doaj   +1 more source

Septic arthritis by Nocardia farcinica: Case report and literature review

open access: yesIDCases, 2023
Nocardiosis is a bacterial infection caused by organisms of the Nocardia genus. The disease typically involves the skin, central nervous system or pulmonary system.
Abhishek Thakur   +2 more
doaj   +1 more source

Endobronchial Nocardiosis associated with Broncholithiasis

open access: yesMonaldi Archives for Chest Disease, 2016
Pulmonary nocardiosis is a rare respiratory infection which commonly affects immunocompromised patients but also in immunocompetent hosts. The clinical manifestation is variable and endobronchial nocardiosis is a very rare condition.
W.O. Tam, C.F. Wong, P.C. Wong
doaj   +1 more source

A rare case of pure N4-acetyl-sulfamethoxazole nephrolithiasis associated with trimethoprim-sulfamethoxazole treatment of pulmonary nocardiosis

open access: yesUrology Case Reports, 2022
Trimethoprim-Sulfamethoxazole is a commonly used antibiotic for treatment of urinary tract infections, but also used to treat less common conditions such as pulmonary nocardiosis.
Andrew Shanholtzer   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy